Paid Clinical Trials in Lancaster, PA
As of July 2026, 73 paid clinical trials are recruiting in Lancaster, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lancaster offers studies at sites including Lancaster General Hospital for conditions such as Heart Failure, Amblyopia, Neoplasm Metastasis, Non-small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lancaster
Filter results
0 clinical trials
·Clear filters·Top Research Study Locations in Lancaster
Researchers run research studies in Lancaster, PA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Lancaster General Hospital | Abdominal Wound Dehiscence, Advanced Cancer, Anal Fistula | 12 |
| Keystone Urology Specialists | FGFR Gene Alterations, FGFR Gene Amplification, FGFR3 Gene Alteration | 8 |
| Lancaster General Hospital - Ann B Barshinger Cancer Institute | Neoplasm Metastasis, Breast Neoplasms, Carcinoma, Transitional Cell | 7 |
| Lancaster General Ann B Barshinger Cancer Institute | Breast Cancer, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 5 |
| Lancaster General Health | Cancer, Cardiovascular Disease and Lipoprotein(a), Hypertension | 4 |
| Penn Medicine Lancaster General Health | Burnout, Professional, Cardiovascular Diseases, Functional Mitral Regurgitation | 4 |
| Conestoga Eye | Amblyopia | 3 |
| Amish Research Clinic | Diabetes Type 2, Hyperglycemia, Obesity | 2 |
| Penn Medicine Lancaster General | AV Block, Heart Failure, Heart Failure With Reduced Ejection Fraction | 2 |
| US Digestive Health | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| University of Maryland Amish Research Clinic | Diabetes, Ethics, Familial Hypercholesterolemia | 2 |
| Advanced Surgery Center of Lancaster | Lumbar Spinal Stenosis | 1 |
| Ann B Barshinger Cancer Institute | Ovarian Cancer | 1 |
| Ann B. Barshinger Cancer Institute | Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 1 |
| Cardiology Care for Children | Cardiomyopathy | 1 |
| Clinical Trial Site | Transthyretin Amyloidosis With Cardiomyopathy | 1 |
| Lancaster Gen Health | Lumbar Spinal Stenosis | 1 |
| Lancaster General Health - Ann B. Barshinger Cancer Institute | Cervical Cancer, Endometrial Cancer, Uterine Cancer | 1 |
| Local Institution - 0288 | Non-Small Cell Lung Cancer (NSCLC) | 1 |
| Penn Lancaster General Health Research Institute | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| Penn Med. Lancaster Gen Hospital | Heart Failure, Obesity | 1 |
| Penn Medicine - Lancaster General Hospital | Metastatic Breast Cancer | 1 |
| Penn Medicine Lancaster General Hospital | Moderate Aortic Valve Stenosis | 1 |
| Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute | Neoplasm Metastasis, Ureteral Neoplasms, Urinary Bladder Neoplasms | 1 |
| Regional GI | Crohn's Disease, Inflammatory Bowel Diseases, Ulcerative Colitis | 1 |
Active & Upcoming Studies in Lancaster (2026)
Recruiting trials in Lancaster grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (33 active studies)
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) · Phase 3 · Bristol-Myers Squibb
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract · Phase 3 · Eli Lilly and Company
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Diabetes & metabolic (3 active studies)
- Pharmacogenetics of Response to Sitagliptin (PRS) · Phase 4 · University of Maryland, Baltimore
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Neurology & pain (1 active study)
- MyStroke for Stroke Survivors and Caregivers · University of Pennsylvania
Pediatric (1 active study)
- Vancomycin Reduction Practices (VRP) in the NICU · Children's Hospital of Philadelphia
Common conditions studied in Lancaster
- Heart Failure (4 active studies)
- Amblyopia (3 active studies)
- Neoplasm Metastasis (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Breast Cancer (2 active studies)
- Endometrial Cancer (2 active studies)
Leading research sponsors in Lancaster
- AstraZeneca
- Abramson Cancer Center at Penn Medicine
- Bristol-Myers Squibb
- NRG Oncology
- University of Maryland, Baltimore
Frequently asked questions
How many paid clinical trials are currently recruiting in Lancaster?
There are approximately 73 recruiting clinical trials in Lancaster, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lancaster pay participants?
Most recruiting trials in Lancaster compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lancaster?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lancaster?
The most common conditions under active study in Lancaster include Heart Failure (4), Amblyopia (3), Neoplasm Metastasis (3), Non-small Cell Lung Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lancaster?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lancaster on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lancaster?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lancaster?
Recruiting research sites in Lancaster include Lancaster General Hospital, Keystone Urology Specialists, Lancaster General Hospital - Ann B Barshinger Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lancaster right now?
The largest active categories in Lancaster are Cancer & tumors (33), Cardiovascular (10), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.